Delfi Diagnostics Stock
Delfi Diagnostics is a biotechnology company specializing in the development of advanced blood test systems for early cancer detection. Its innovative technology uses machine learning to analyze blood and genome samples, identifying cancer-associated DNA fragments.
Founded: 2019
For more Delfi Diagnostics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Susan Tousi Chief Executive Officer |
| Victor Velculescu Co-Founder & Board Member |
| Jennifer Buechel Chief Operating Officer & President |
| Doug Schenkel Chief Financial Officer & Head of Strategy |
| Nicholas Dracopoli Co-Founder & Chief Scientific Officer |
| Jessica Meng Chief Commercial Officer |
| Alessandro Leal Co-Founder & Medical Director of Translational Research |
| Robert Scharpf Co-Founder & Head of Computational Biology |
| Peter Bach Chief Medical Officer |
